Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis - Test2 - elhamkhani - TriplyDB

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

http://www.wikidata.org/entity/Q34067511

about

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts Combination HIV prevention: significance, challenges, and opportunities Medication adherence and HIV symptom distress in relation to panic disorder among HIV-positive adults managing opioid dependence Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals Preexposure chemoprophylaxis for HIV prevention in men who have sex with men Combination prevention: new hope for stopping the epidemic Prevention of HIV-1 infection with early antiretroviral therapy Sexuality and Reproduction in HIV-Positive Women: A Meta-Synthesis Gender difference in advanced HIV disease and late presentation according to European consensus definitions Protocol for a systematic review: understanding the motivations and barriers to uptake and use of female-initiated, primary biomedical HIV prevention technologies in sub-Saharan Africa Effectiveness of ART and condom use for prevention of sexual HIV transmission in serodiscordant couples: a systematic review and meta-analysis Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis Impact of viral load and the duration of primary infection on HIV transmission: systematic review and meta-analysis A systematic review of evidence to inform HIV prevention interventions among men who have sex with men in Europe HIV-1 prevention for HIV-1 serodiscordant couples Antiretroviral therapy for prevention of HIV transmission: implications for Europe Contraceptive methods and risk of HIV acquisition or female-to-male transmission Systematic review and meta-analysis of hepatitis C virus infection and HIV viral load: new insights into epidemiologic synergy HIV treatment as prevention: contradictory perspectives from dynamic mathematical models Antiretroviral prophylaxis for HIV prevention in heterosexual men and women Age-targeted HIV treatment and primary prevention as a 'ring fence' to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South Africa Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda Novel use of surveillance data to detect HIV-infected persons with sustained high viral load and durable virologic suppression in New York City Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010 A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study HIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, China Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting Evaluation of a HIV voluntary opt-out screening program in a Singapore hospital Poor Linkage to Care Despite Significant Improvement in Access to Early cART in Central Poland - Data from Test and Keep in Care (TAK) Project Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050

P2860

Q21034169-E02D8B28-A6BA-4210-92F7-4B19585E8B2C Q21133704-92E70EF9-5C3C-4997-9B70-DB3270A61743 Q21135264-6EDF40B4-D474-4108-B134-3EAC1F04CBBD Q21144606-E336DC8F-F94A-4982-9AAC-9EBB5010BB7F Q22241321-1F772446-3D73-427A-8E95-2A66B7049EA8 Q22252603-411D072E-5F94-4FEA-9F45-7A4BE2A1B2E2 Q23914817-2EC3ECEE-1FC1-4C35-9416-44D6F77F1C45 Q24197939-5645642F-49C4-4271-874C-8DCCD37050C5 Q24201955-D5269648-F2B9-4290-9AE8-830FD4B98A7F Q24612082-69A2188B-DB50-4BE1-BE27-EAF608AB5EE2 Q24630559-09AAE380-FB70-480E-A3E0-BFE2E4DE616D Q24634688-F4573D71-B3FD-4E24-93FC-6B11CB5FAACD Q26770318-5CB66708-8D8D-4BD4-B81A-3E27C89B13C0 Q26786152-5DFCEB20-A9C5-492B-B6A1-227D1E01DA68 Q26796724-0F576106-05D8-44DB-910C-652310B50E75 Q26824382-32EA9177-835B-41B5-93CC-18CB3463FDF3 Q26825761-759B0E33-3601-4E7C-910E-E078A76C7EAD Q26828443-DE944BE2-D087-4885-B4B2-A246C1A48A03 Q26861475-1508B8FC-5E61-44B3-983F-DC18E94BE3BE Q26866244-6F35FCFF-DD5E-471C-8709-902FAF626F28 Q26996011-BE81D7AC-BCC3-4B79-A187-27830FF0D845 Q27023464-8BBC22FF-03FD-4560-994B-F23FFBC6D7E3 Q27027323-66CBA0E6-9D73-4C53-992B-725690A46824 Q28077305-7CE3C332-B2B2-4C26-8153-6DF89DF1BF18 Q28080917-9F93E78C-0CAE-41CD-9F64-F52F88D5BECE Q28270788-3DEEF197-6838-46AA-AEEC-B63ABFFCBAD4 Q28385587-1808CC62-66B8-49C0-A6B9-2021543802E0 Q28397243-329FC9FA-3930-481D-8E9C-7408732872A8 Q28478923-4AD4040D-6AEB-4628-A46E-E38A351CB3C1 Q28479045-E8FE4FCF-EEB8-4E7D-A784-1C569D39BB3E Q28481603-5B90701E-2B55-4F08-A9A8-FB207D5D21D1 Q28483747-AB02F5F8-5AEF-4D81-9175-FBDD59966B89 Q28483820-2C71F685-0B88-4EA9-BCCE-941458349DE4 Q28488157-AFC22B2B-39B9-4104-AC55-FDCF0AA5C7CF Q28534017-B3D59D23-7641-447B-A148-B71B0F7B2001 Q28534568-C3367DBE-DB99-4B0D-8C58-A15E2313D61B Q28539721-F358C308-E3FE-4770-BB0B-059A5A67DCF9 Q28543053-80674938-1CB2-4318-81C3-D6E9E218833C Q28597880-03E46200-25FE-4325-8024-030AA97AC627 Q28732123-2FFB6DB5-F132-4401-8404-268929417480

P2860

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

http://www.wikidata.org/entity/Q34067511

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@ast

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@en

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@nl

type

label

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@ast

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@en

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@nl

prefLabel

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@ast

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@en

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@nl

P1433

Q34067511-01B9D1D0-2376-4376-8A60-405F0CD001C2

P1476

Q34067511-F0203039-F817-48A6-9260-B76AE027013C

P2093

Q34067511-59957B72-C4D0-43DD-AE69-F41185B38B3E

Q34067511-73F6E0D4-8C2E-4989-9621-5D043B099C57

Q34067511-8E6ED262-C3B8-413E-A351-FBCFE367A858

Q34067511-8F53A7B1-A5E0-4150-934C-94B792C36651

Q34067511-A98E5F75-74CC-4021-833F-801DA333E4F5

Q34067511-E733ED90-ABB4-414E-A5B9-1BCE562E61F6

Q34067511-FAA8743F-526D-4529-95E5-D913D3ED3314

P2860

Q34067511-23BD3605-D75C-4302-847E-AE70D868B86A

Q34067511-255453DF-9B27-4D12-89B9-D3FD838FF401

Q34067511-3E84B867-EAC9-49F4-985F-2E61FF7B1BA4

Q34067511-42FD185E-C674-45B7-BDD2-2E9F4FC70786

Q34067511-5A75E367-6971-4E4D-AFE2-440C996FDCA6

Q34067511-5DB5FEEC-1FD2-462B-8F74-06C39E6012EC

Q34067511-639AFC5D-F325-4442-B500-4EA84D66EBC7

Q34067511-83C5854F-3A0B-4F8C-973D-8C56AC1AD9A0

Q34067511-84B9AC4A-7BD8-4C62-A7DE-C4F8128C6DD8

Q34067511-9C01C9B9-80BD-4978-A2D8-984BF03E8EA0

P304

Q34067511-0282CA96-79C8-4195-B175-E7AE3F69AD6A

P31

Q34067511-3BCA12D8-C080-4592-8853-2D3FAE534E2B

P356

Q34067511-4D367041-5DEF-40F8-8F6D-218598018B5A

P407

Q34067511-6CCCF90E-8AD6-41C9-86D9-2D73F8984F26

P433

Q34067511-D7F6AE25-458B-40D3-9DE6-87C9FE7D2AA3

P478

Q34067511-F887DF1B-8E0F-4320-B536-289594CB882E

P50

Q34067511-036E3D82-C5CB-4B00-A848-A0185D0B6BF6

Q34067511-18A97F53-37AC-4C2E-A21F-6466130CFC91

Q34067511-7D23C77A-9F0C-45A6-92FA-0CD63D4ABE97

Q34067511-AB75D319-2CD8-4A7B-A59D-29EF698A91D7

P577

Q34067511-5CEE2829-34BC-49F7-AEAC-6A64C3DADD07

P5875

Q34067511-28C43166-8ED6-4201-8638-0CA9A7FE0885

P698

Q34067511-0A63F8EF-2138-47CE-928D-D5D57B46E3BC

P921

Q34067511-29A7D07E-9044-468C-9E9F-0D588157498D

Q34067511-F1D1B4C2-EF47-4FDB-8757-A1AE7671083B

P932

Q34067511-5F49C429-A1FD-41E9-BB5F-5353DC1DCDF0

P356

S0140-6736(10)60705-2

P1433

P1476

Heterosexual HIV-1 transmissio ...... a prospective cohort analysis

@en

P2093

Jairam R Lingappa

http://www.w3.org/2001/XMLSchema#string

James Kiarie

http://www.w3.org/2001/XMLSchema#string

James McIntyre

http://www.w3.org/2001/XMLSchema#string

Jared M Baeten

http://www.w3.org/2001/XMLSchema#string

Katherine K Thomas

http://www.w3.org/2001/XMLSchema#string

Partners in Prevention HSV/HIV Transmission Study Team

http://www.w3.org/2001/XMLSchema#string

Wendy Stevens

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study.

Treatment to prevent transmission of HIV-1

High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.

Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression

Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.

P304

2092-2098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(10)60705-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

9731

http://www.w3.org/2001/XMLSchema#string

P478

375

http://www.w3.org/2001/XMLSchema#string

P50

Deborah Donnell

Partners in Prevention HSV/HIV Transmission Study Team

P577

2010-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44662866

http://www.w3.org/2001/XMLSchema#string

P698

20537376

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission

antiretroviral drug

P932

2922041

http://www.w3.org/2001/XMLSchema#string